Warning: This security is no longer trading.
Biogen has completed its acquisition of Nightstar Therapeutics
Nightstar Therapeutics plc (NITE): Price and Financial Metrics Recent IPO
NITE Price/Volume Stats
| Current price | $28.89 | 52-week high | $29.24 |
| Prev. close | $29.02 | 52-week low | $22.21 |
| Day low | $28.67 | Volume | 700 |
| Day high | $28.89 | Avg. volume | 3,644 |
| 50-day MA | $26.59 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 25.13M |
NITE Stock Price Chart Interactive Chart >
Nightstar Therapeutics plc (NITE) Company Bio
Nightstar Therapeutics Limited, a clinical-stage gene therapy company, focuses on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded in 2013 and is based in London, the United Kingdom.
NITE Price Returns
| 1-mo | 9.56% |
| 3-mo | 18.40% |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...